- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03907709
Effects of In-Home Addiction Treatment for First Responders
August 5, 2019 updated by: In-Home Addiction Treatment Institute, Inc.
Effects of an In-Home Treatment Program for First Responders With Substance Use Disorder: A Retrospective Analysis
Retrospective analysis to evaluate impact of an in-home addiction treatment program on first responders with substance use disorder.
Study Overview
Status
Suspended
Conditions
Intervention / Treatment
Detailed Description
The purpose of this retrospective study is to evaluate the effects of in-home addiction treatment on first responders with substance use disorder.
Treatment engagement, hospitalizations, detox and residential addiction treatment admissions, and lethal overdoses will be measured.
Although not the primary focus, recidivism and relapse will be measured.
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
North Haven, Connecticut, United States, 06473
- Aware Recovery Care
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Approximately 15 individuals with substance use disorder who are or have served as a first responder (police officer, fire fighter, corrections officer, military police, emergency medical technician, paramedic, parole or probation officer) and were enrolled in Aware Recovery Care's In-Home Addiction Treatment program between April 2017 and March 2019.
Description
Inclusion Criteria:
- Client is or has been a first responder
- Client enrolled in Aware Recovery Care after April 2017
- Client discharged from Aware Recovery Care before March 2019
- Client has primary substance use disorder diagnosis
Exclusion Criteria:
- Client has never been first responder
- Client moved out of service area or lost insurance during care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
First Responders in In-Home Addiction Treatment Program
- First responders (individual who does or has worked as a police officer, fire fighter, corrections officer, military police, emergency medical technician, paramedic, parole or probation officer)
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Retention in Treatment
Time Frame: Measured throughout 365 day duration of anticipated length of stay
|
Participation in In-Home Addiction Treatment Program using length of stay reports
|
Measured throughout 365 day duration of anticipated length of stay
|
Brief Addiction Monitor questionnaire
Time Frame: Conducted monthly throughout 365 day anticipated length of stay in program
|
Measure change in client report of symptoms related to substance use disorder
|
Conducted monthly throughout 365 day anticipated length of stay in program
|
Positive Outcomes Measures Survey
Time Frame: Completed at week 3 or 4, Week 30, Week 35, Week 44, and Week 50 throughout 52 week anticipated length of program participation
|
Measures changes in quality of life using client self-report inquiring about employment, connection to care team, community engagement using yes/no/not applicable response scale
|
Completed at week 3 or 4, Week 30, Week 35, Week 44, and Week 50 throughout 52 week anticipated length of program participation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Relapse rates
Time Frame: Randomly administered throughout 365 day anticipated length of program participation
|
Occurrence of substance use measured through urine drug screening and breathalyzer tests
|
Randomly administered throughout 365 day anticipated length of program participation
|
Hospitalization
Time Frame: Measured throughout 365 day anticipated length of program participation
|
Occurrence of Emergency Room and Inpatient hospital admissions
|
Measured throughout 365 day anticipated length of program participation
|
Detox and Residential Admissions
Time Frame: Measured throughout 365 day anticipated length of program participation
|
Occurrence of residential treatment and detox admission
|
Measured throughout 365 day anticipated length of program participation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sara Kaiser, MS Ed, LPN, In-Home Addiction Treatment Institute, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 8, 2019
Primary Completion (Anticipated)
May 28, 2020
Study Completion (Anticipated)
July 28, 2020
Study Registration Dates
First Submitted
April 5, 2019
First Submitted That Met QC Criteria
April 5, 2019
First Posted (Actual)
April 9, 2019
Study Record Updates
Last Update Posted (Actual)
August 7, 2019
Last Update Submitted That Met QC Criteria
August 5, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IHATI-2019-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingSubstance Use | Substance Use Disorders | Substance DependenceUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Istanbul UniversityCompletedSubstance Use | Substance Use Disorders | Substance AbuseTurkey
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedPTSD | Alcohol Use Disorders | Substance Use DisordersUnited States
Clinical Trials on In-Home Addiction Treatment Program
-
Wake Forest University Health SciencesCompleted
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedMood Disorders | Schizophrenia | Substance DependenceUnited States
-
Corporal Michael J. Crescenz VA Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedAged | Concerns About FallingNetherlands
-
Federico II UniversityCompleted
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA)Not yet recruitingSubstance UseUnited States
-
The University of Texas Health Science Center at...Completed
-
University GhentInBev-Baillet Latour Fund; Baluchon Alzheimer Belgium vzwCompleted
-
Louise PenzenstadlerRecruitingSubstance Use DisordersSwitzerland
-
Mahidol UniversityRecruitingAutism Spectrum Disorder | AutismThailand